Literature DB >> 2427139

On the identity of vitronectin and S-protein: immunological crossreactivity and functional studies.

B R Tomasini, D F Mosher.   

Abstract

Vitronectin (serum spreading factor), a major serum cell adhesion molecule, was compared with S-protein, the inhibitor of the C5-9 membrane attack complex. Data from the literature indicate that S-protein and vitronectin are alpha globulins with the same aminoterminal residues, amino acid compositions, and concentrations in normal plasma (150 to 250 micrograms/mL). Both proteins have been reported to interact with the thrombin-antithrombin complex. The cDNA sequences of vitronectin and S-protein were recently determined and found to be almost identical. In the present studies, rabbit-anti-S-protein and a monoclonal antibody to vitronectin both recognized 65,000- and 75,000-molecular weight (mol wt) polypeptides when plasma or serum proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose paper. The 65,000 and 75,000-mol wt polypeptides bound more avidly from serum than plasma to monoclonal anti-vitronectin or heparin coupled to agarose. The presence or absence of the polypeptides constituted a major difference between the heparin-binding proteins of serum and plasma. When complement-activated serum and unactivated serum were separated by gel filtration, vitronectin coeluted with C9 in high-mol-wt fractions of activated serum but not unactivated serum. Purified S-protein was recognized by the monoclonal antibody to vitronectin and promoted spreading of human skin fibroblasts. Both vitronectin and S-protein were degraded by thrombin. On the basis of immunological and functional, as well as biochemical, properties, therefore, S-protein and vitronectin are the same.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427139

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Specific binding of the human S protein (vitronectin) to streptococci, Staphylococcus aureus, and Escherichia coli.

Authors:  G S Chhatwal; K T Preissner; G Müller-Berghaus; H Blobel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

2.  Terminal complement complex (TCC) and S-protein (vitronectin) on follicular dendritic cells in human lymphoid tissues.

Authors:  T S Halstensen; T E Mollnes; P Brandtzaeg
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

3.  Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries.

Authors:  C Guettier; N Hinglais; P Bruneval; M Kazatchkine; J Bariety; J P Camilleri
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 4.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

5.  Detection of vitronectin mRNA in tissues and cells of the mouse.

Authors:  D Seiffert; M Keeton; Y Eguchi; M Sawdey; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

6.  Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy.

Authors:  M Weller; P Wiedemann; M Bresgen; K Heimann
Journal:  Int Ophthalmol       Date:  1991-03       Impact factor: 2.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.